European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 0.63% to 1,525.33 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by consumer goods giant Unilever (UL) and petroleum refiner Equinor (EQNR), which increased 2.7% and 2.4%, respectively. They were followed by pharmaceutical company Sanofi (SNY) and brewing company Anheuser-Busch InBev (BUD), which were up 1.9% and 1.5%, respectively.
The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and biotech firm Evaxion (EVAX), which lost 4.7% and 3.5%, respectively. They were followed by semiconductor company Sequans Communications (SQNS) and internet browser company Opera (OPRA), which were down 3.4% and 3.1%, respectively.
From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech (TRIB) and tobacco company British American Tobacco (BTI), which advanced 25% and 2.3%, respectively. They were followed by pharmaceutical company GSK (GSK) and financial services company HSBC (HSBC), which rose 2.1% each.
The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana (NCNA) and Biodexa Pharmaceuticals (BDRX), which fell 9.8% and 4.2%, respectively. They were followed by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and Mereo BioPharma Group (MREO), which dropped 2.4% each.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。